Glutathione and Tranexamic Acid are commonly used together for managing dullness and pigmentation Glutathione provides antioxidant support and helps modulate melanin production, while Tranexamic Acid blocks the specific cell-signalling pathway that triggers excess pigment formation, making the combination especially useful for stubborn or melasma-related dark spots
Independently tested for purity, sterility, endotoxins, and heavy metalsbecause quality should be proven
These timelines can change based on safety data, trial outcomes, and regulatory decisions
The combination of GLP-1 receptor agonists and DPP-4 inhibitors is not recommended, not due to safety issues, but since a clinically significant additional benefit is not expected (see below) (7072)
Limited Treatment Options for Diabetic Wounds: Barriers to Clinical Translation Despite Therapeutic Success in Murine Models